Tuesday, November 3, 2020

Markets rally on election day

Dow surged 647, advancers over decliners about 6-1 & NAZ shot up 231.  The MLP index added 1+ to the 112s & the REIT index gained 5+ to the 348s.  Junk bond funds traded higher & Treasuries were sold.  Oil advanced 1+ to the 38s & gold rose 14 to 1907.   

AMJ (Alerian MLP index tracking fund)
 
stock chart

CL=FCrude Oil37.90
  +1.09+3.0%
























GC=FGold   1,906.10
+13.60+0.7%





















 




3 Stocks You Should Own Right Now - Click Here!

 

The coronavirus outbreak in the US will likely get so bad that the country will see more than 1K Covid-19 deaths per day for a “sustained period of time,” former Food & Drug Administration Commissioner Dr Scott Gottlieb said.  The US reported more than 84K new cases of the virus & 557 new deaths caused by Covid-19, according to data compiled by Johns Hopkins University.  The number of deaths recorded tends to fall far below the average, historical data shows.  The country has reported an average of 835 daily new Covid-19 deaths per day over the past week.  That's far lower than the daily death toll this spring, when an average of more than 2K people were dying each day from the disease, mostly in New York state.  During the summer surge that followed Memorial Day, the country reported about 1K deaths per day in Aug.  Gottlieb said the next couple of months could prove to be “the densest phase of the pandemic.”  “We’re probably going to see significant spread across the entire United States in a confluent epidemic that we’re much better prepared to deal with, so I don’t think that we’re going to see the excess death that we saw with the first wave of this pandemic when it struck New York,” he added.  “But the sheer fact that we’re going to be infecting so many people right now is probably going to mean that the death tolls get well above 1,000 for a sustained period of time.”

Dr. Scott Gottlieb warns of a ‘sustained period’ in U.S. of ‘well above’ 1,000 Covid deaths per day

US factory orders rose 1.1% in Sep to mark the 5th straight gain, pointing to a steady recovery in the manufacturing segment of the economy.  The forecast called for a 1% increase.  Orders for durable goods made to last at least 3 years climbed 1.9% in Sep, the same as the original reading.  Orders for nondurable goods such as clothing & food products rose a smaller 0.3%.  Manufacturers have rebounded faster than the much larger service side of the US economy and have shown little letup despite a fresh coronavirus outbreak.

U.S. factory orders climb 1.1% in September

Humana (HUM) reported 3rd-qtr profit & revenue that beat expectations & raised its full-year outlook for Medicare Advantage membership growth.  EPS was $10.05, about double $5.14 in the year-ago period.  Excluding non-recurring items, such as changes in market value of publicly traded securities & the receipt of commercial risk corridor receivables previously written off, adjusted EPS fell to $3.08 from $5.03, but beat the estimate of $2.81.  Revenue rose 23.6% to $20.08B, or grew 15.9% to $18.82B on an adjusted basis.  The forecast was for revenue of $18.6B.  The company boosted its 2020 guidance for Medicare Advantage membership growth to about 375K from 330-360K.  "We continue to see more Medicare beneficiaries choosing Medicare Advantage (MA) plans over Medicare-Fee-For-Service due to MA's ever-increasing value proposition," said CEO Bruce Broussard.  "What's driving this strong value is the fact that plans must constantly innovate to stay competitive as Medicare beneficiaries have the freedom to choose a plan that's affordable for them and that suits their lifestyle needs."  The stock soared 21.17 (5%).
If you would like to learn more about HUM, click on this link:
club.ino.com/trend/analysis/stock/HUM?a_aid=CD3289&a_bid=6ae5b6f7  

Humana beats profit and revenue expectations, boosts MA membership growth outlook

Investors are feeling great & are bidding stocks higher, adding to yesterday's advance.  However the election remains close & uncertain with widely different predictions for the outcome. 

Dow Jones Industrials

 
 






 

No comments: